Abstract:
OBJECTIVE:To examine the likelihood of response with continued galcanezumab treatment in patients with episodic or chronic migraine without initial clinical improvement. BACKGROUND:A percentage of patients with migraine may require additional time on pharmacotherapy but discontinue treatment prematurely. Additionally, recognizing when continued treatment is unlikely to provide improvement limits unnecessary exposure. METHODS:Post hoc analysis of response after continued galcanezumab treatment was conducted in a subset of patients with episodic (N = 879) and chronic (N = 555) migraine who did not achieve "good" early improvement (episodic, ≥50% reduction in baseline migraine headache days [MHD] and chronic, ≥30% reduction) after 1 month of dosing (NR-1; episodic, n = 450 and chronic, n = 306). This subset was categorized by level of reduction in MHD during 1 month of treatment: "modest" (>30% to <50% fewer MHD for episodic and >10% to <30% fewer MHD for chronic), "limited" (episodic only; >10% to ≤30% fewer MHD), or "minimal/no" early improvement (≤10% fewer MHD to ≤10% more MHD), or "worsening" (>10% more MHD). The percentages of patients having "better" (≥75% fewer MHD for episodic and ≥50% for chronic), "good," or "little-to-no" (≤10% fewer MHD) response during the remaining treatment period were calculated for each category. Similarly, the subset of NR-1 patients who did not achieve "good" early improvement after 2 months of treatment (NR-2; episodic, n = 290 and chronic, n = 240) were categorized by level of their average monthly reduction across 1 and 2 months using similar categories. RESULTS:Of NR-1 patients with episodic migraine having "modest" early improvement, 62% (96/155) achieved "good" and 20% (31/155) achieved "better" responses with continued treatment. A percentage of patients with "limited" (43%; 46/108) or "minimal/no" (34%; 29/85) early improvement, or "worsening" (20%; 20/102) achieved a "good" response after continued treatment. A percentage of NR-1 patients with chronic migraine having "modest" early improvement achieved "good" (38%; 44/116) and "better" (13%; 15/116) responses with continued treatment. A "good" response was achieved for a percentage of patients with "minimal/no" early improvement (17%; 23/133). Similar patterns were observed for the NR-2 subset, though percentages were lower. CONCLUSIONS:Galcanezumab-treated patients with episodic or chronic migraine without response following 1 or 2 months of treatment appear to have a reasonable likelihood of continued improvement in months following initial treatment and this opportunity is more likely in patients showing greater early improvements. While a small percentage of patients with episodic or chronic migraine who experienced worsening in the number of MHD following initial treatment responded with continued treatment, most do not show substantial reduction in MHD. Overall benefit of therapy should be determined collaboratively between the patient and physician.
journal_name
Headachejournal_title
Headacheauthors
Nichols R,Doty E,Sacco S,Ruff D,Pearlman E,Aurora SKdoi
10.1111/head.13443subject
Has Abstractpub_date
2019-02-01 00:00:00pages
192-204issue
2eissn
0017-8748issn
1526-4610journal_volume
59pub_type
杂志文章,随机对照试验相关文献
HEADACHE文献大全abstract::Many investigators have described olfactory dysfunction among migraineurs. Olfactory stimuli can precipitate migraine, and olfactory hallucinations can occur as auras of migraines or as part of the symptom complex. Despite many reports linking olfactory phenomena and migraine, no evaluations of the olfactory abilities...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.1992.hed3205233.x
更新日期:1992-05-01 00:00:00
abstract::Two telephone surveys were conducted at a major headache center into patient compliance with follow-up and perceived treatment efficacy. The first survey addressed compliance with the recommendation to follow-up after the initial evaluation. Of a group of 316 consecutive patients, 40.5% had not complied with the recom...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.1993.hed33040205.x
更新日期:1993-04-01 00:00:00
abstract::To investigate the pathophysiology of muscle contraction headache (MCH), several parameters of inflammation were evaluated in 48 patients suffering from MCH, and compared with 50 healthy control subjects: erythrocyte sedimentation rate; C-reactive protein; white blood cell count; immunoglobulin (Ig) G, A, M; and compl...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.1991.hed3108543.x
更新日期:1991-09-01 00:00:00
abstract::Subarachnoid hemorrhage as a complication of acupuncture has been reported in only a few cases. We report another case and discuss the implications of subarachnoid hemorrhage following acupuncture. Although acupuncture has traditionally been thought to be relatively safe, physicians should be aware that it may be a ca...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2008.01139.x
更新日期:2008-09-01 00:00:00
abstract::Flunarizine is a non-selective calcium antagonist. It distributes preferentially in the adipose tissue and passes the blood brain barrier. Numerous controlled clinical studies have established that flunarizine is efficacious in migraine prophylaxis, including double-blind studies in which the drug was compared with pl...
journal_title:Headache
pub_type: 临床试验,杂志文章,随机对照试验,评审
doi:10.1111/j.1526-4610.1991.hed3106388.x
更新日期:1991-06-01 00:00:00
abstract:OBJECTIVE:To compare, using a within-woman analysis, the severity, duration, and relapse of menstrual vs nonmenstrual episodes of migraine during treatment with usual migraine therapy. BACKGROUND:Studies comparing the clinical characteristics of menstrual and nonmenstrual migraine attacks have yielded conflicting resu...
journal_title:Headache
pub_type: 临床试验,杂志文章,多中心研究
doi:10.1111/j.1526-4610.2010.01625.x
更新日期:2010-04-01 00:00:00
abstract::Seven hundred three subjects completed a randomized, double-blind, parallel-group, single-center study comparing the single-dose efficacy of ketoprofen 12.5 mg, ketoprofen 25 mg, acetaminophen 1000 mg, and placebo in the treatment of tension headache. For the primary efficacy variable, 4-hour sum of pain relief intens...
journal_title:Headache
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1046/j.1526-4610.1998.3808579.x
更新日期:1998-09-01 00:00:00
abstract:OBJECTIVE:To determine the brain structures involved in mediating the pain of hemicrania continua using positron emission tomography. BACKGROUND:Hemicrania continua is a strictly unilateral, continuous headache of moderate intensity, with superimposed exacerbations of severe intensity that are accompanied by trigemina...
journal_title:Headache
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1111/j.1526-4610.2004.04141.x
更新日期:2004-09-01 00:00:00
abstract:OBJECTIVE:Our study aims to examine factors related to access of triptans among multiple stakeholder groups. BACKGROUND:Triptans are a cornerstone of pain management for the acute treatment of migraine, but actual utilization of triptans is lower than ideal. Initial and continued access to triptans may be an important...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.12593
更新日期:2015-07-01 00:00:00
abstract:OBJECT:To investigate the rhythmicity of migraine episodes without aura in a pediatric population. METHODS:Time of occurrence of 2517 migraine attacks in 115 children was recorded, by means of a diary, both by hourly and monthly intervals. RESULTS:A significant circadian variation, characterized by a peak in the afte...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2006.00613.x
更新日期:2006-11-01 00:00:00
abstract:OBJECTIVE:This study aims to investigate the psychometric properties (component structure, reliability, and construct validity) of the Headache-Specific Locus of Control scale in several clinical migraine populations. BACKGROUND:Headache-specific locus of control beliefs may impact a person's behavioral decisions that...
journal_title:Headache
pub_type: 杂志文章,随机对照试验
doi:10.1111/head.13485
更新日期:2019-05-01 00:00:00
abstract:BACKGROUND:The sequence and timing of taking migraine medications, whether prescription or over-the-counter, and the patient's response to their treatment, is unknown. OBJECTIVE:To describe the use of, response to, and satisfaction with acute medications for 1 migraine attack. METHODS:We performed a clinic-based surv...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2006.00437.x
更新日期:2006-05-01 00:00:00
abstract:OBJECTIVE:This study aimed to evaluate the association between misdiagnosis of spontaneous intracranial hypotension (SIH) and subdural hematoma development. BACKGROUND:Although SIH is more prevalent than expected and causes potentially life-threatening complications including subdural hematoma (SDH), the association b...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13132
更新日期:2017-11-01 00:00:00
abstract:OBJECTIVE:To assess the efficacy of melatonin as a preventive therapy for hemicrania continua in a larger population of patients than has previously been studied. BACKGROUND:Hemicrania continua is defined by its sensitivity to indomethacin. Rarely can patients be fully tapered off indomethacin without headache recurre...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.12489
更新日期:2015-03-01 00:00:00
abstract::Two cases of baroreflex failure presented with tension-type/exertional headache. The usefulness of noninvasive physiological tests in diagnosing baroreflex failure and the role of baroreceptors in trigeminal nociception are discussed. ...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2006.00514_3.x
更新日期:2006-07-01 00:00:00
abstract:OBJECTIVE:To investigate similarities and differences between patients with cluster headache and patients with migraine. BACKGROUND:Patients with migraine and patients with cluster headache are considered, by many clinical neurologists, to be different psychologically and socially. METHODS:Twenty-five age-matched pai...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.2002.02049.x
更新日期:2002-03-01 00:00:00
abstract::The clinical science of migraine headache continues to evolve. Theories of the pathophysiology of migraine have progressed from the early vascular basis of migraine to more complex current theories that emphasize the centrality of neuronal dysfunction. The most recently articulated theory of migraine is the central se...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/j.1526-4610.2006.00602.x
更新日期:2006-11-01 00:00:00
abstract::We present a novel case of a focal stabbing headache sharing features of primary stabbing headache that started and resolved with the onset and resolution of a course of self-limiting peripheral vertigo. The association of onset and improvement of the stabbing headaches support the trigeminal and vestibular reciprocal...
journal_title:Headache
pub_type: 信件
doi:10.1111/head.13208
更新日期:2018-01-01 00:00:00
abstract::A 57-year-old woman presented with an escalation of her headaches which ultimately progressed to multiple strokes and death. MRI/MRA demonstrated diffuse vasospasm and other causes of stroke were excluded on premortem investigation and postmortem examination. Reversible MRI abnormalities, vasospasm on angiogram and fa...
journal_title:Headache
pub_type: 信件
doi:10.1111/j.1526-4610.2007.00695.x
更新日期:2007-02-01 00:00:00
abstract:BACKGROUND:In patients with episodic migraine (EM), diffusion tensor imaging (DTI) revealed microstructural white matter alterations in various brain regions related to pain processing. Some of these changes were correlated with migraine duration and attack frequency, suggesting that migraine is a progressive disease w...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.12496
更新日期:2015-02-01 00:00:00
abstract::A 25-year-old female patient developed headache and papilledema under sulphasalazine treatment for ulcerative colitis. The patient met the International Headache Society's criteria for idiopathic intracranial hypertension. Sulphasalazine was discontinued and the patient was given azathioprine for ulcerative colitis an...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2007.00992.x
更新日期:2008-02-01 00:00:00
abstract:OBJECTIVE:To evaluate triptan use patterns in a large Israeli HMO district. BACKGROUND:Triptans, 5HT(1B/1D) agonists, provide an effective and safe relief of headache and accompanying symptoms during an acute migraine attack. METHOD:We retrospectively reviewed the computerized prescription filling data of 1498 patien...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2006.00435.x
更新日期:2006-09-01 00:00:00
abstract:OBJECTIVES:This study evaluated the long-term safety of oral almotriptan 12.5 mg for the treatment of multiple migraine episodes in adolescents over a 12-month period. Efficacy outcomes were assessed as a secondary objective. METHODS:Adolescent migraineurs aged 12-17 years were enrolled in this 12-month, open-label st...
journal_title:Headache
pub_type: 临床试验,杂志文章,多中心研究
doi:10.1111/j.1526-4610.2010.01655.x
更新日期:2010-05-01 00:00:00
abstract:BACKGROUND:A vascular component in ergotamine-induced headache has been proposed. No study has been carried out to evaluate cerebral hemodynamic changes by means of transcranial Doppler during withdrawal from migraine medication; in particular, ergotamine-containing drugs. METHOD:We examined 21 patients suffering from...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.1998.3809679.x
更新日期:1998-10-01 00:00:00
abstract::Although severe short-lasting headaches are rare, they can be considered disabling conditions with a major impact on the quality of life of patients. These headaches can divided broadly in to those associated with autonomic symptoms, so called trigeminal autonomic cephalgias (TACs), and those with few or no autonomic ...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/head.12213
更新日期:2013-10-01 00:00:00
abstract:OBJECTIVE:Previous attempts to develop a pragmatic human model for testing new anti-migraine drugs, have failed. Calcitonin gene-related peptide (CGRP) induces a mild headache in healthy volunteers and migraine-like headache in migraine patients. The induced headache must respond to already established migraine treatme...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13747
更新日期:2020-04-01 00:00:00
abstract::Calcitonin-gene-related peptide (CGRP), a neuropeptide broadly distributed in neuronal and non-neuronal regions throughout the body, plays a fundamental role in migraine and cluster headache (CH) pathophysiology. CGRP functional blockade alleviates neurogenic inflammation and reduces pain pathway sensitization. Two ty...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/head.13583
更新日期:2019-07-01 00:00:00
abstract:OBJECTIVE:In this study, we explored the relationship between migraine and sport in a physically active population of students, analyzing the risk of migraine among sporty students. BACKGROUND:The relationship between sport and migraine is controversial; moreover, several studies report on sport as a migraine trigger,...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.14015
更新日期:2020-11-01 00:00:00
abstract:OBJECTIVES:This cross-sectional study examined the association between adverse childhood experiences (ACEs) and history of frequent headaches (including migraine) among children 3-17 years old using data from the 2016 and 2017 U.S. National Survey of Children's Health (NSCH). BACKGROUND:ACEs include abuse (physical, e...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13773
更新日期:2020-04-01 00:00:00
abstract:BACKGROUND:Fast relief of migraine pain, associated symptoms, and migraine-related disability are priorities in the acute treatment of migraine. Efforts to improve the pharmacokinetic profiles of acute migraine treatments with the aim of providing faster relief include the development of non-oral routes of administrati...
journal_title:Headache
pub_type: 杂志文章,随机对照试验
doi:10.1111/head.13165
更新日期:2017-11-01 00:00:00